loadpatents
name:-0.05385684967041
name:-0.026754856109619
name:-0.021780967712402
Poirot; Laurent Patent Filings

Poirot; Laurent

Patent Applications and Registrations

Patent applications and USPTO patent grants for Poirot; Laurent.The latest application filed is for "cellular immunotherapy for repetitive administration".

Company Profile
21.22.48
  • Poirot; Laurent - Paris FR
  • Poirot; Laurent - San Diego CA
  • POIROT; Laurent - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
Grant 11,414,674 - Galetto , et al. August 16, 2
2022-08-16
Cellular Immunotherapy For Repetitive Administration
App 20220233588 - SOURDIVE; David ;   et al.
2022-07-28
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 11,365,430 - Duchateau , et al. June 21, 2
2022-06-21
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20220177914 - GALETTO; Roman ;   et al.
2022-06-09
Methods for engineering highly active T cell for immunotherapy
Grant 11,311,575 - Galetto , et al. April 26, 2
2022-04-26
Methods for engineering allogeneic and highly active t cell for immunotherapy
Grant 11,304,975 - Galetto , et al. April 19, 2
2022-04-19
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
Grant 11,274,316 - Galetto , et al. March 15, 2
2022-03-15
Inhibitory Chimeric Antigen Receptors
App 20220033462 - RAJPAL; ARVIND ;   et al.
2022-02-03
Methods for engineering allogeneic T cell to increase their persistence and/or engraftment into patients
Grant 11,186,824 - Duchateau , et al. November 30, 2
2021-11-30
Inhibitory chimeric antigen receptors
Grant 11,072,644 - Rajpal , et al. July 27, 2
2021-07-27
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20210220405 - GALETTO; Roman ;   et al.
2021-07-22
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20210147868 - DUCHATEAU; Philippe ;   et al.
2021-05-20
Engineered Immune Cells Resistant To Tumor Microenvironment
App 20210128613 - DUCHATEAU; Philippe ;   et al.
2021-05-06
Chimeric antigen receptors with integrated controllable functions
Grant 10,988,542 - Juillerat , et al. April 27, 2
2021-04-27
Method of engineering drug-specific hypersensitive t-cells for immunotherapy by gene inactivation
Grant 10,894,093 - Valton , et al. January 19, 2
2021-01-19
Targeted Gene Integration Of Crs Inhibitor Genes For Improved Immune Cells Therapy
App 20200407694 - BUSSER; Brian ;   et al.
2020-12-31
Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells
App 20200407682 - DUCHATEAU; Philippe ;   et al.
2020-12-31
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 10,870,864 - Duchateau , et al. December 22, 2
2020-12-22
Method For Generating Immune Cells Resistant To Arginine And/or Tryptophan Depleted Microenvironment
App 20200384094 - Poirot; Laurent ;   et al.
2020-12-10
Cells for immunotherapy engineered for targeting antigen present both on immune cells and pathological cells
Grant 10,836,998 - Duchateau , et al. November 17, 2
2020-11-17
Method For Improving Production Of Car T Cells
App 20200332004 - BOYNE; Alex ;   et al.
2020-10-22
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy
App 20200281979 - GALETTO; Roman ;   et al.
2020-09-10
Method for generating immune cells resistant to arginine and/or tryptophan depleted microenvironment
Grant 10,765,728 - Poirot , et al. Sep
2020-09-08
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20200277625 - DUCHATEAU; Philippe ;   et al.
2020-09-03
Targeted Gene Integration Of Nk Inhibitors Genes For Improved Immune Cells Therapy
App 20200237823 - BUSSER; Brian ;   et al.
2020-07-30
Targeted Gene Insertion For Improved Immune Cells Therapy
App 20200224163 - BUSSER; Brian ;   et al.
2020-07-16
Methods Of Antigen-dependent Chimeric Antigen Receptor (car) Immune Cell Selection
App 20200216515 - DUCHATEAU; Philippe ;   et al.
2020-07-09
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20200181643 - DUCHATEAU; Philippe ;   et al.
2020-06-11
Protease Based Switch Chimeric Antigen Receptors For Safer Cell Immunotherapy
App 20200140560 - Duchateau; Philippe ;   et al.
2020-05-07
Methods for engineering T cells for immunotherapy by using RNA-guided Cas nuclease system
Grant 10,584,352 - Duchateau , et al.
2020-03-10
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
Grant 10,517,896 - Galetto , et al. Dec
2019-12-31
Method for modulating car-induced immune cells activity
Grant 10,472,613 - Duchateau , et al. Nov
2019-11-12
Cell Death Inducing Chimeric Antigen Receptors
App 20190338015 - JUILLERAT; Alexandre ;   et al.
2019-11-07
A Method Of Engineering Prodrug-specific Hypersensitive T-cells For Immunotherapy By Gene Expression
App 20190328783 - VALTON; Julien ;   et al.
2019-10-31
Use of preTalpha or functional variant thereof for expanding TCRalpha deficient T cells
Grant 10,426,795 - Galetto , et al. October 1, 2
2019-10-01
Stably Enginereed Proteasome Inhibitor Resistant Immune Cells For Immunotherapy
App 20190290694 - GAUTRON; Anne-Sophie ;   et al.
2019-09-26
Methods for engineering allogeneic and immunosuppressive resistant T cell immunotherapy
Grant 10,363,270 - Galetto , et al.
2019-07-30
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20190216854 - GALETTO; Roman ;   et al.
2019-07-18
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20190216853 - GALETTO; Roman ;   et al.
2019-07-18
A Method Of Engineering Drug-specific Hypersensitive T-cells For Immunotherapy By Gene Inactivation
App 20190151478 - VALTON; Julien ;   et al.
2019-05-23
Use of pre T alpha or functional variant thereof for expanding TCR alpha deficient T cells
Grant 10,286,007 - Galetto , et al.
2019-05-14
Method of engineering multi-input signal sensitive T cell for immunotherapy
Grant 10,239,948 - Juillerat , et al.
2019-03-26
Method for in situ inhibition of regulatory T cells
Grant 10,196,608 - Poirot , et al. Fe
2019-02-05
Method For Generating T-cells Compatible For Allogenic Transplantation
App 20190010514 - POIROT; Laurent ;   et al.
2019-01-10
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy
App 20180360883 - GALETTO; Roman ;   et al.
2018-12-20
Process Of Gene-editing Of Cells Isolated From A Subject Suffering From A Metabolic Disease Affecting The Erythroid Lineage, Cells Obtained By Said Process And Uses Thereof
App 20180320138 - SEGOVIA SANZ; Jose Carlos ;   et al.
2018-11-08
Methods For Engineering Allogeneic T Cell To Increase Their Persistence And/or Engraftment Into Patients
App 20180291343 - DUCHATEAU; Philippe ;   et al.
2018-10-11
Chimeric Antigen Receptors With Integrated Controllable Functions
App 20180237533 - JUILLERAT; Alexandre ;   et al.
2018-08-23
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20180237798 - DUCHATEAU; Philippe ;   et al.
2018-08-23
Method For In Situ Inhibition Of Regulatory T Cells
App 20180208896 - POIROT; Laurent ;   et al.
2018-07-26
Cells For Immunotherapy Engineered For Targeting Antigen Present Both On Immune Cells And Pathological Cells
App 20180201901 - DUCHATEAU; Philippe ;   et al.
2018-07-19
Inhibitory Chimeric Antigen Receptors
App 20180044399 - RAJPAL; Arvind ;   et al.
2018-02-15
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
Grant 9,890,393 - Duchateau , et al. February 13, 2
2018-02-13
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy
App 20180021379 - GALETTO; Roman ;   et al.
2018-01-25
Methods for engineering T cells for immunotherapy by using RNA-guided CAS nuclease system
Grant 9,855,297 - Duchateau , et al. January 2, 2
2018-01-02
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20170360835 - GALETTO; Roman ;   et al.
2017-12-21
INHIBITORY CHIMERIC ANTIGEN RECEPTOR (iCAR OR N-CAR) EXPRESSING NON-T CELL TRANSDUCTION DOMAIN
App 20170296623 - JUILLERAT; Alexandre ;   et al.
2017-10-19
Method For Modulating Car-induced Immune Cells Activity
App 20170292118 - DUCHATEAU; Philippe ;   et al.
2017-10-12
Method Of Engineering Multi-input Signal Sensitive T Cell For Immunotherapy
App 20170073423 - JUILLERAT; Alexandre ;   et al.
2017-03-16
Method For In Situ Inhibition Of Regulatory T Cells
App 20170067022 - Poirot; Laurent ;   et al.
2017-03-09
Method For Generating Immune Cells Resistant To Arginine And/or Tryptophan Depleted Microenvironment
App 20170035866 - POIROT; Laurent ;   et al.
2017-02-09
Method For Generating T-cells Compatible For Allogenic Transplantation
App 20170016025 - POIROT; Laurent ;   et al.
2017-01-19
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20160272999 - DUCHATEAU; Philippe ;   et al.
2016-09-22
Methods For Engineering T Cells For Immunotherapy By Using Rna-guided Cas Nuclease System
App 20160184362 - DUCHATEAU; Philippe ;   et al.
2016-06-30
Methods For Engineering Allogeneic And Highly Active T Cell For Immunotheraphy
App 20160120905 - GALETTO; Roman ;   et al.
2016-05-05
Methods For Engineering Highly Active T Cell For Immunotheraphy
App 20160120906 - GALETTO; Roman ;   et al.
2016-05-05
Use Of Pre T Alpha Or Functional Variant Thereof For Expanding Tcr Alpha Deficient T Cells
App 20150203817 - Galetto; Roman ;   et al.
2015-07-23
Methods For Engineering Allogeneic And Highly Active T Cell For Immunotherapy
App 20150017136 - GALETTO; ROMAN ;   et al.
2015-01-15
Methods For Engineering Allogeneic And Immunosuppressive Resistant T Cell For Immunotherapy
App 20130315884 - Galetto; Roman ;   et al.
2013-11-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed